Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Expedited SARS‐CoV‐2 main protease inhibitor discovery through modular 'direct‐to‐biology' screening

Title: Expedited SARS‐CoV‐2 main protease inhibitor discovery through modular 'direct‐to‐biology' screening
Authors: Wilders, Harry; Biggs, George; Rowe, Sam M.; Cawood, Emma E.; Riziotis, Ioannis G.; Rendina, Alan R.; Grant, Emma K.; Pettinger, Jonathan; Fallon, David J.; Skehel, Mark; House, David; Tomkinson, Nicholas C. O.; Bush, Jacob T.
Publication Year: 2025
Collection: University of Strathclyde Glasgow: Strathprints
Subject Terms: Chemistry
Description: Reactive fragment (RF) screening has emerged as an efficient method for ligand discovery across the proteome, irrespective of a target's perceived tractability. To date, however, the efficiency of subsequent optimisation campaigns has largely been low‐throughput, constrained by the need for synthesis and purification of target compounds. We report an efficient platform for ‘direct‐to‐biology’ (D2B) screening of cysteine‐targeting chloroacetamide RFs, wherein synthesis is performed in 384‐well plates allowing direct assessment in downstream biological assays without purification. Here, the developed platform was used to optimise inhibitors of SARS‐CoV‐2 main protease (MPro), an established drug target for the treatment of COVID‐19. An initial RF hit was developed into a series of potent inhibitors, and further exploration using D2B screening enabled a ‘switch’ to a reversible inhibitor series. This example of ligand discovery for MPro illustrates the acceleration that D2B chemistry can offer for optimising RFs towards covalent inhibitor candidates, as well as providing future impetus to explore the evolution of RFs into non‐covalent ligands.
Document Type: article in journal/newspaper
File Description: text
Language: unknown
ISSN: 1521-3773
Relation: https://strathprints.strath.ac.uk/91567/1/Wilders-etal-ACIE-2024-Expedited-SARS-CoV-2-main-protease-inhibitor-discovery.pdf; Wilders, Harry and Biggs, George and Rowe, Sam M. and Cawood, Emma E. and Riziotis, Ioannis G. and Rendina, Alan R. and Grant, Emma K. and Pettinger, Jonathan and Fallon, David J. and Skehel, Mark and House, David and Tomkinson, Nicholas C. O. and Bush, Jacob T. (2025 ) Expedited SARS‐CoV‐2 main protease inhibitor discovery through modular 'direct‐to‐biology' screening. Angewandte Chemie , 137 (6). e202418314. ISSN 1521-3773
DOI: 10.1002/ange.202418314
Availability: https://strathprints.strath.ac.uk/91567/; https://doi.org/10.1002/ange.202418314
Rights: cc_by
Accession Number: edsbas.D40AE452
Database: BASE